YB
Yuanbao Inc. American Depositary Shares
Insurance - Diversified
Market Cap$119M
5Y Perf.-0.7%
Compare Stocks
2 / 10Try these comparisons:
Stock Comparison
YB vs ACMR
Revenue, margins, valuation, and 5-year total return — side by side.
ACMR
ACM Research, Inc.
Semiconductors
Market Cap$3.92B
5Y Perf.+204.1%
YB vs ACMR — Key Financials
Market cap, revenue, margins, and valuation side-by-side.
| Company Snapshot | YB | ACMR |
|---|---|---|
| Industry | Insurance - Diversified | Semiconductors |
| Market Cap | $119M | $3.92B |
| Revenue (TTM) | $4.09B | $901M |
| Net Income (TTM) | $1.26B | $94M |
| Gross Margin | 95.8% | 44.4% |
| Operating Margin | 30.1% | 12.1% |
| Forward P/E | 0.5x | 29.7x |
| Total Debt | $19M | $303M |
| Cash & Equiv. | $1.90B | $766M |
YB vs ACMR — Long-Term Stock Performance
Price return indexed to 100 at period start. Dividends excluded.
YB
ACMR
| Stock | Apr 25 | May 26 | Return |
|---|---|---|---|
| Yuanbao Inc. Americ… (YB) | 100 | 99.3 | -0.7% |
| ACM Research, Inc. (ACMR) | 100 | 304.1 | +204.1% |
Price return only. Dividends and distributions are not included.
Quick Verdict: YB vs ACMR
Each card shows where this stock fits in a portfolio — not just who wins on paper.
Bottom line: YB leads in 5 of 7 categories, making it the strongest pick for growth and revenue expansion and valuation and capital efficiency. ACM Research, Inc. is the stronger pick specifically for dividend income and shareholder returns and recent price momentum and sentiment. This set spans 2 sectors — these stocks serve different portfolio roles, not just different price points.
YB
Yuanbao Inc. American Depositary Shares
The Insurance Pick
YB carries the broadest edge in this set and is the clearest fit for income & stability and growth exposure.
- beta 1.13
- Rev growth 60.6%, EPS growth 360.0%, 3Y rev CAGR 104.3%
- Lower volatility, beta 1.13, current ratio 2.84x
Best for: income & stability and growth exposure
ACMR
ACM Research, Inc.
The Long-Run Compounder
ACMR is the clearest fit if your priority is long-term compounding.
- 30.7% 10Y total return vs YB's -0.7%
- 0.2% yield; 3-year raise streak; the other pay no meaningful dividend
- +195.6% vs YB's +5.8%
Best for: long-term compounding
See the full category breakdown
| Category | Winner | Why |
|---|---|---|
| Growth | YB | 60.6% revenue growth vs ACMR's 15.2% |
| Value | YB | Lower P/E (0.5x vs 29.7x) |
| Quality / Margins | YB | 30.9% margin vs ACMR's 10.4% |
| Stability / Safety | YB | Beta 1.13 vs ACMR's 3.24 |
| Dividends | ACMR | 0.2% yield; 3-year raise streak; the other pay no meaningful dividend |
| Momentum (1Y) | ACMR | +195.6% vs YB's +5.8% |
| Efficiency (ROA) | YB | 35.6% ROA vs ACMR's 3.9% |
YB vs ACMR — Revenue Breakdown by Segment
How each company's revenue is distributed across its business units
Segment breakdown not available.
FY 2025
YB vs ACMR — Financial Metrics
Side-by-side numbers across 2 stocks — who leads on profitability, valuation, growth, and risk.
BEST OVERALLYBLAGGINGACMR
ACMRACM Research, Inc.
1leads
YBYuanbao Inc. American…
3leads
6 Total Categories
CATEGORYLEADERvs ACMRMETRICS WON
Income & Cash FlowRevenue, margins, and cash flow strength
YB6/6
Valuation MetricsMultiples, price ratios, and targets
YB4/4
Profitability & EfficiencyROE, ROIC, leverage, and quality scores
YB6/6
Total Returns1Y, 3Y, 5Y total returns with dividends
ACMR6/6
Risk & VolatilityBeta, volatility, and downside exposure
Tied
—
Analyst OutlookRatings, price targets, and dividends
—
—
Income & Cash Flow (Last 12 Months)
YB leads this category, winning 6 of 6 comparable metrics.
Income & Cash Flow (Last 12 Months)
YB is the larger business by revenue, generating $4.1B annually — 4.5x ACMR's $901M. YB is the more profitable business, keeping 30.9% of every revenue dollar as net income compared to ACMR's 10.4%. On growth, YB holds the edge at +33.6% YoY revenue growth, suggesting stronger near-term business momentum.
| Metric | YBYuanbao Inc. Amer… | ACMRACM Research, Inc. |
|---|---|---|
| RevenueTrailing 12 months | $4.1B | $901M |
| EBITDAEarnings before interest/tax | $1.2B | $126M |
| Net IncomeAfter-tax profit | $1.3B | $94M |
| Free Cash FlowCash after capex | $277M | -$69M |
| Gross MarginGross profit ÷ Revenue | +95.8% | +44.4% |
| Operating MarginEBIT ÷ Revenue | +30.1% | +12.1% |
| Net MarginNet income ÷ Revenue | +30.9% | +10.4% |
| FCF MarginFCF ÷ Revenue | +6.8% | -7.6% |
| Rev. Growth (YoY)Latest quarter vs prior year | +33.6% | +9.4% |
| EPS Growth (YoY)Latest quarter vs prior year | +4.9% | -76.1% |
YB leads this category, winning 6 of 6 comparable metrics.
Valuation Metrics
YB leads this category, winning 4 of 4 comparable metrics.
Valuation Metrics
At 0.9x trailing earnings, YB trades at a 98% valuation discount to ACMR's 43.2x P/E.
| Metric | YBYuanbao Inc. Amer… | ACMRACM Research, Inc. |
|---|---|---|
| Market CapShares × price | $119M | $3.9B |
| Enterprise ValueMkt cap + debt − cash | -$158M | $3.5B |
| Trailing P/EPrice ÷ TTM EPS | 0.94x | 43.21x |
| Forward P/EPrice ÷ next-FY EPS est. | 0.49x | 29.68x |
| PEG RatioP/E ÷ EPS growth rate | — | 1.22x |
| EV / EBITDAEnterprise value multiple | -1.23x | 27.49x |
| Price / SalesMarket cap ÷ Revenue | 0.25x | 4.35x |
| Price / BookPrice ÷ Book value/share | — | 2.06x |
| Price / FCFMarket cap ÷ FCF | 0.67x | — |
YB leads this category, winning 4 of 4 comparable metrics.
Profitability & Efficiency
YB leads this category, winning 6 of 6 comparable metrics.
Profitability & Efficiency
YB delivers a 189.2% return on equity — every $100 of shareholder capital generates $189 in annual profit, vs $6 for ACMR. On the Piotroski fundamental quality scale (0–9), YB scores 8/9 vs ACMR's 2/9, reflecting strong financial health.
| Metric | YBYuanbao Inc. Amer… | ACMRACM Research, Inc. |
|---|---|---|
| ROE (TTM)Return on equity | +189.2% | +6.1% |
| ROA (TTM)Return on assets | +35.6% | +3.9% |
| ROICReturn on invested capital | — | +7.0% |
| ROCEReturn on capital employed | +63.0% | +6.6% |
| Piotroski ScoreFundamental quality 0–9 | 8 | 2 |
| Debt / EquityFinancial leverage | — | 0.16x |
| Net DebtTotal debt minus cash | -$1.9B | -$463M |
| Cash & Equiv.Liquid assets | $1.9B | $766M |
| Total DebtShort + long-term debt | $19M | $303M |
| Interest CoverageEBIT ÷ Interest expense | — | 20.44x |
YB leads this category, winning 6 of 6 comparable metrics.
Total Returns (Dividends Reinvested)
ACMR leads this category, winning 6 of 6 comparable metrics.
Total Returns (Dividends Reinvested)
A $10,000 investment in ACMR five years ago would be worth $23,344 today (with dividends reinvested), compared to $9,931 for YB. Over the past 12 months, ACMR leads with a +195.6% total return vs YB's +5.8%. The 3-year compound annual growth rate (CAGR) favors ACMR at 80.5% vs YB's -0.2% — a key indicator of consistent wealth creation.
| Metric | YBYuanbao Inc. Amer… | ACMRACM Research, Inc. |
|---|---|---|
| YTD ReturnYear-to-date | -20.8% | +31.9% |
| 1-Year ReturnPast 12 months | +5.8% | +195.6% |
| 3-Year ReturnCumulative with dividends | -0.7% | +487.9% |
| 5-Year ReturnCumulative with dividends | -0.7% | +133.4% |
| 10-Year ReturnCumulative with dividends | -0.7% | +3065.8% |
| CAGR (3Y)Annualised 3-year return | -0.2% | +80.5% |
ACMR leads this category, winning 6 of 6 comparable metrics.
Risk & Volatility
Evenly matched — YB and ACMR each lead in 1 of 2 comparable metrics.
Risk & Volatility
YB is the less volatile stock with a 1.13 beta — it tends to amplify market swings less than ACMR's 3.24 beta. A beta below 1.0 means the stock typically moves less than the S&P 500. ACMR currently trades 82.6% from its 52-week high vs YB's 51.1% drawdown — a narrower gap to the peak suggests stronger recent price momentum.
| Metric | YBYuanbao Inc. Amer… | ACMRACM Research, Inc. |
|---|---|---|
| Beta (5Y)Sensitivity to S&P 500 | 1.13x | 3.24x |
| 52-Week HighHighest price in past year | $31.00 | $71.65 |
| 52-Week LowLowest price in past year | $14.04 | $19.26 |
| % of 52W HighCurrent price vs 52-week peak | +51.1% | +82.6% |
| RSI (14)Momentum oscillator 0–100 | 34.6 | 60.7 |
| Avg Volume (50D)Average daily shares traded | 42K | 1.2M |
Evenly matched — YB and ACMR each lead in 1 of 2 comparable metrics.
Analyst Outlook
Insufficient data to determine a leader in this category.
Analyst Outlook
ACMR is the only dividend payer here at 0.19% yield — a key consideration for income-focused portfolios.
| Metric | YBYuanbao Inc. Amer… | ACMRACM Research, Inc. |
|---|---|---|
| Analyst RatingConsensus buy/hold/sell | — | Buy |
| Price TargetConsensus 12-month target | — | $40.00 |
| # AnalystsCovering analysts | — | 10 |
| Dividend YieldAnnual dividend ÷ price | — | +0.2% |
| Dividend StreakConsecutive years of raises | — | 3 |
| Dividend / ShareAnnual DPS | — | $0.11 |
| Buyback YieldShare repurchases ÷ mkt cap | 0.0% | +0.2% |
Insufficient data to determine a leader in this category.
Key Takeaway
YB leads in 3 of 6 categories (Income & Cash Flow, Valuation Metrics). ACMR leads in 1 (Total Returns). 1 tied.
Best OverallYuanbao Inc. American Depos… (YB)Leads 3 of 6 categories
Loading custom metrics...
YB vs ACMR: Frequently Asked Questions
10 questions · data-driven answers · updated daily
01Is YB or ACMR a better buy right now?
For growth investors, Yuanbao Inc.
American Depositary Shares (YB) is the stronger pick with 60. 6% revenue growth year-over-year, versus 15. 2% for ACM Research, Inc. (ACMR). Yuanbao Inc. American Depositary Shares (YB) offers the better valuation at 0. 9x trailing P/E (0. 5x forward), making it the more compelling value choice. Analysts rate ACM Research, Inc. (ACMR) a "Buy" — based on 10 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.
02Which has the better valuation — YB or ACMR?
On trailing P/E, Yuanbao Inc.
American Depositary Shares (YB) is the cheapest at 0. 9x versus ACM Research, Inc. at 43. 2x. On forward P/E, Yuanbao Inc. American Depositary Shares is actually cheaper at 0. 5x.
03Which is the better long-term investment — YB or ACMR?
Over the past 5 years, ACM Research, Inc.
(ACMR) delivered a total return of +133. 4%, compared to -0. 7% for Yuanbao Inc. American Depositary Shares (YB). Over 10 years, the gap is even starker: ACMR returned +30. 7% versus YB's -0. 7%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.
04Which is safer — YB or ACMR?
By beta (market sensitivity over 5 years), Yuanbao Inc.
American Depositary Shares (YB) is the lower-risk stock at 1. 13β versus ACM Research, Inc. 's 3. 24β — meaning ACMR is approximately 185% more volatile than YB relative to the S&P 500.
05Which is growing faster — YB or ACMR?
By revenue growth (latest reported year), Yuanbao Inc.
American Depositary Shares (YB) is pulling ahead at 60. 6% versus 15. 2% for ACM Research, Inc. (ACMR). On earnings-per-share growth, the picture is similar: Yuanbao Inc. American Depositary Shares grew EPS 360. 0% year-over-year, compared to -10. 5% for ACM Research, Inc.. Over a 3-year CAGR, YB leads at 104. 3% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.
06Which has better profit margins — YB or ACMR?
Yuanbao Inc.
American Depositary Shares (YB) is the more profitable company, earning 26. 4% net margin versus 10. 4% for ACM Research, Inc. — meaning it keeps 26. 4% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: YB leads at 26. 1% versus 12. 1% for ACMR. At the gross margin level — before operating expenses — YB leads at 94. 9%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.
07Is YB or ACMR more undervalued right now?
On forward earnings alone, Yuanbao Inc.
American Depositary Shares (YB) trades at 0. 5x forward P/E versus 29. 7x for ACM Research, Inc. — 29. 2x cheaper on a one-year earnings basis.
08Which pays a better dividend — YB or ACMR?
In this comparison, ACMR (0.
2% yield) pays a dividend. YB does not pay a meaningful dividend and should not be held primarily for income.
09Is YB or ACMR better for a retirement portfolio?
For long-horizon retirement investors, Yuanbao Inc.
American Depositary Shares (YB) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β 1. 13)). ACM Research, Inc. (ACMR) carries a higher beta of 3. 24 — meaning larger drawdowns in market downturns, which matters significantly when you cannot wait years for a recovery. Both have compounded well over 10 years (YB: -0. 7%, ACMR: +30. 7%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.
10What are the main differences between YB and ACMR?
These companies operate in different sectors (YB (Financial Services) and ACMR (Technology)), which means they face different economic cycles, regulatory environments, and macro sensitivities — making direct comparison nuanced.
These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.
Find Stocks Like These
Explore pre-built screens for each stock's profile, or build a custom screen to find stocks that outperform both.
Revenue Growth>
%
(YB: 33.6% · ACMR: 9.4%)Net Margin>
%
(YB: 30.9% · ACMR: 10.4%)P/E Ratio<
x
(YB: 0.9x · ACMR: 43.2x)You Might Also Compare
Based on how these companies actually compete and overlap — not just which sector they're filed under.